Retaglutide is a innovative GLP-1 receptor agonist currently under investigation for the treatment of type 2 diabetes. This drug works by stimulating the effects of glucagon-like peptide-1 (GLP-1), a naturally https://brendadyhv932136.ampblogs.com/trelaglutide-exploring-a-new-treatment-for-chronic-diseases-75749185